Perceptive Imaging Improves Oncology Trial Outcomes through Enhanced Services
Radialogica joins Perceptive's supplier network to standardize radiotherapy treatments and enable more reliable safety and efficacy determinations
There is growing concern about the amount of variability in radiotherapy treatments among investigative sites and its potential impact on pharmaceutical efficacy and toxicity evaluations. This presents a need to centrally evaluate the conformance of radiotherapy plans to the treatment guidelines for a given protocol.
"By incorporating Radialogica's radiotherapy quality management services into Perceptive's centralized imaging workflows, we're helping worldwide clinical trial sponsors overcome this challenge," said
"We're delighted to partner with Perceptive Imaging and to work closely with their team of oncology imaging specialists to provide critical radiotherapy-related services and data to trial sponsors in order to advance the development of new oncology treatments," said
Click here for information on Perceptive Imaging's extensive experience supporting oncology clinical trials.
About Perceptive
Perceptive is a leading global technology-enabled service provider for preclinical and clinical trial imaging and IRT/RTSM (Interactive Response Technology/Randomized Trial Supply Management) for drug developers and the global clinical research community. Perceptive's market-leading service, scientific knowledge, expertise, and technology offering help speed up the delivery of life-saving treatments to millions of patients around the world by accelerating and improving clinical trial outcomes. With operations in the US,
Visit Perceptive.com and follow Perceptive Inc. on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/perceptive-imaging-improves-oncology-trial-outcomes-through-enhanced-services-302310351.html
SOURCE Perceptive
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fermi Inc. Admission of shares of Common Stock and Total Voting Rights
- AS Tallink Grupp Unaudited Consolidated Interim Report for the Q2 2026
- AkzoNobel and Axalta enhance governance arrangements following shareholder dialogue
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share